Department of Parasitology and Tropical Medicine, School of Medicine, Inha University, Incheon, Republic of Korea.
Department of Medical Environmental Biology and Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Republic of Korea.
Front Cell Infect Microbiol. 2024 Jan 12;13:1321240. doi: 10.3389/fcimb.2023.1321240. eCollection 2023.
is the most widely distributed human malaria parasite. The eradication of vivax malaria remains challenging due to transmission of drug-resistant parasite and dormant liver form. Consequently, anti-malarial drugs with novel mechanisms of action are urgently demanded. Glucose uptake blocking strategy is suggested as a novel mode of action that leads to selective starvation in various species of malaria parasites. The role of hexose transporter 1 in species is glucose uptake, and its blocking strategies proved to successfully induce selective starvation. However, there is limited information on the glucose uptake properties via hexose transporter 1 (PvHT1). Thus, we focused on the PvHT1 to precisely identify its properties of glucose uptake. The PvHT1 North Korean strain (PvHT1) expressed oocytes mediating the transport of [H] deoxy-D-glucose (ddGlu) in an expression and incubation time-dependent manner without sodium dependency. Moreover, the PvHT1 showed no exchange mode of glucose in efflux experiments and concentration-dependent results showed saturable kinetics following the Michaelis-Menten equation. Non-linear regression analysis revealed a Km value of 294.1 μM and a Vmax value of 1,060 pmol/oocyte/hr, and inhibition experiments showed a strong inhibitory effect by glucose, mannose, and ddGlu. Additionally, weak inhibition was observed with fructose and galactose. Comparison of amino acid sequence and tertiary structure between and HT1 revealed a completely conserved residue in glucose binding pocket. This result supported that the glucose uptake properties are similar to , and PfHT1 inhibitor (compound 3361) works in . These findings provide properties of glucose uptake via PvHT1 for carbohydrate metabolism and support the approaches to vivax malaria drug development strategy targeting the PvHT1 for starving of the parasite.
是分布最广的人类疟原虫。由于耐药寄生虫和休眠肝脏形式的传播,消除间日疟仍然具有挑战性。因此,迫切需要具有新型作用机制的抗疟药物。葡萄糖摄取阻断策略被认为是一种新的作用模式,可导致各种疟原虫物种的选择性饥饿。1 型在 物种中起着葡萄糖摄取的作用,其阻断策略已被证明可成功诱导选择性饥饿。然而,关于通过 1 型己糖转运蛋白(PvHT1)摄取葡萄糖的性质的信息有限。因此,我们专注于 PvHT1,以准确确定其葡萄糖摄取特性。朝鲜株 PvHT1(PvHT1)在没有钠离子依赖性的情况下,以表达和孵育时间依赖的方式表达卵母细胞,介导[H]脱氧-D-葡萄糖(ddGlu)的转运。此外,PvHT1 在流出实验中没有表现出交换模式的葡萄糖,浓度依赖性结果表明米氏方程遵循饱和动力学。非线性回归分析显示 Km 值为 294.1 μM,Vmax 值为 1060 pmol/卵母细胞/小时,抑制实验显示葡萄糖、甘露糖和 ddGlu 具有很强的抑制作用。此外,果糖和半乳糖也观察到较弱的抑制作用。与 HT1 的氨基酸序列和三级结构比较表明,葡萄糖结合口袋中的完全保守残基。该结果支持葡萄糖摄取特性与 相似,PfHT1 抑制剂(化合物 3361)在 中起作用。这些发现为通过 PvHT1 摄取葡萄糖提供了碳水化合物代谢特性,并支持针对 PvHT1 的间日疟药物开发策略,以饿死寄生虫。